USFDA issues import alert for Ranbaxy Mohali facilities

4 просмотров 16.02.2018 00:02:24

Описание

In a major blow to Ranbaxy Laboratories, USFDA has imposed a ban against its Mohali facilities. This ban is likely to impact Ranbaxy's export plans. Mint's CH Unnikrishnan has more on this

Комментарии

Теги:
USFDA, issues, import, alert, Ranbaxy, Mohali, facilities